Drug Database
Back to search

Belgium· BE-AMP-SAM185507-00

Vesanoid 10 mg

A tretinoin product containing tretinoin, registered in Belgium by Cheplapharm Arzneimittel. The same ATC class is registered in 8 of our 19 countries.

ATC L01XF01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVesanoid 10 mgATCL01XF01REGISTER NO.BE-AMP-SAM185507-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tretinoinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tretinoin is registered in 8 of 19 countries.

Countries holding a registration under ATC L01XF01 (tretinoin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose
Search tretinoin products by name

Tretinoin · ATC L01XF01

8 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Tretinoin
Manufacturer
Cheplapharm Arzneimittel
Country
Belgium (BE)
ATC code
L01XF01
ATC class
Tretinoin
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    1358365
    EUR 333.96
  • be_apb
    0760512

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

366 interactions on record for tretinoin.

Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tretinoin against other medicinesHow interaction checks work

Tretinoin · interactions on record

366 records

  • 29 severe
  • 101 moderate
  • 17 minor
  • 219 info

Most severe, free to view

  • Aminocaproic acidB02AA01severe
  • Tranexamic acidB02AA02severe
  • AprotininB02AB01severe
  • MipomersenC10AX11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tretinoin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tretinoin products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Vesanoid
  • Germany · Cordes Vas, Vesanoid
  • Spain · Neocare, Retirides
  • Finland · Avitcid, Vesanoid
  • France · Effederm, Ketrel
  • United Kingdom (Northern Ireland) · Tretinoin Neon Healthcare, Vesanoid
  • Croatia · Vesanoid
  • Ireland · Vesanoid
  • Italy · Tretinoina Same Savoma Medicinali, Vesanoid
  • Malta · Ketrel
  • Netherlands · Vesanoid
  • Poland · Vesanoid
  • Portugal · Ketrel, Vesanoid
  • Slovakia · Vesanoid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ca746ab9-ad1d-4029-b25a-f9bc255792f0
GET /v1/drugs/ca746ab9-ad1d-4029-b25a-f9bc255792f0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, soft",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Vesanoid 10 mg",
  "name_fr": "Vesanoid 10 mg",
  "name_nl": "Vesanoid 10 mg",
  "amp_code": "SAM185507-00",
  "strengths": [
    "10.0000",
    "27.7500",
    "107.9200",
    "7.6800",
    "30.7200",
    "0.0000",
    "1.9300"
  ],
  "pack_count": 1,
  "substances": [
    "Tretinoin",
    "Glycerol",
    "Glycine max - Glycine soja (Ph.Eur. mixture), Bean, Oil",
    "Glycine max - Glycine soja (Ph.Eur. mixture), Bean, Oil - Hydrogenated",
    "Glycine max - Glycine soja (Ph.Eur. mixture), Bean, Oil - Hydrogenated (partially)",
    "Mannitol",
    "Sorbitol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Tretinoin",
  "authorisation_numbers": [
    "BE185507"
  ]
}
API referenceMCP serverPlans

See everything about tretinoin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console